Mibetin (Betamethasone Dipropionate, Gentamicin Sulfate)

Betamethasone dipropionate is a potent glucocorticoid that binds to intracellular glucocorticoid receptors. This interaction alters gene transcription, leading to decreased production of pro‑inflammatory cytokines, reduced leukocyte migration, and overall suppression of the inflammatory response in the treated skin area.

The prescribed dose of Mibetin is determined by the treating clinician based on the severity of the condition, the area of skin involved, and patient age. Typically, a thin layer is applied to the affected area once or twice daily, but exact frequency and duration should follow the prescriber’s instructions.

Safety data for Mibetin in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks before prescribing it to pregnant or nursing women. The decision to use the product should be made in consultation with a qualified medical professional.

To order Mibetin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Mibetin combines a high‑potency corticosteroid (betamethasone dipropionate) with a broad‑spectrum aminoglycoside (gentamicin). Compared with lower‑potency steroid‑antibiotic products, it may offer faster inflammation control but also carries a higher risk of steroid‑related skin changes. Choice of product should be guided by the severity of inflammation and the susceptibility of the infecting organism.

Store Mibetin at ambient temperature, preferably below 25 °C. Keep the tube or container tightly closed, protect it from moisture and direct sunlight, and store it in its original packaging until use. Do not freeze the product.

Mibetin is applied topically to clean, dry skin. A thin film should be spread over the affected area using clean fingertips or a sterile applicator. The area can be gently massaged until the product is absorbed. Follow the prescriber’s guidance on frequency and duration of treatment.

Serious risks include systemic corticosteroid effects such as adrenal suppression when large skin areas are treated, severe allergic reactions (e.g., anaphylaxis), and secondary infections caused by resistant organisms. Patients should seek immediate medical attention if they notice widespread rash, swelling, difficulty breathing, or signs of infection worsening.

Mibetin should be avoided in individuals with known hypersensitivity to betamethasone, gentamicin, or any excipients in the formulation. It is also contraindicated on viral skin infections (e.g., herpes simplex), fungal infections, or in patients with untreated tuberculosis of the skin. Consultation with a healthcare professional is essential before initiating therapy.